Trevena Inc (TRVN)
0.4126
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.4295
+0.02
(+4.10%)
After-Hours: 20:00
Trevena Cash from Financing (Quarterly): 4.029M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.029M |
| September 30, 2023 | 15.78M |
| June 30, 2023 | 6.503M |
| March 31, 2023 | -0.002M |
| December 31, 2022 | 7.956M |
| September 30, 2022 | 1.10M |
| June 30, 2022 | 14.45M |
| March 31, 2022 | -0.002M |
| December 31, 2021 | -0.271M |
| September 30, 2021 | -0.002M |
| June 30, 2021 | 5.277M |
| March 31, 2021 | 2.73M |
| December 31, 2020 | 3.88M |
| September 30, 2020 | 60.61M |
| June 30, 2020 | 32.03M |
| March 31, 2020 | -1.496M |
| December 31, 2019 | -2.142M |
| September 30, 2019 | -3.176M |
| June 30, 2019 | -3.273M |
| March 31, 2019 | 6.094M |
| December 31, 2018 | -3.17M |
| September 30, 2018 | 10.53M |
| Date | Value |
|---|---|
| June 30, 2018 | 7.201M |
| March 31, 2018 | 6.041M |
| December 31, 2017 | 1.518M |
| September 30, 2017 | 5.508M |
| June 30, 2017 | 6.853M |
| March 31, 2017 | 17.11M |
| December 31, 2016 | 20.40M |
| September 30, 2016 | 0.078M |
| June 30, 2016 | 0.016M |
| March 31, 2016 | 11.84M |
| December 31, 2015 | 16.39M |
| September 30, 2015 | 74.76M |
| June 30, 2015 | 16.26M |
| March 31, 2015 | 0.1788M |
| December 31, 2014 | 47.77M |
| September 30, 2014 | 1.787M |
| June 30, 2014 | 0.0672M |
| March 31, 2014 | 59.56M |
| December 31, 2013 | 0.595M |
| September 30, 2013 | 0.0157M |
| June 30, 2013 | 55.52M |
| March 31, 2013 | -0.5287M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-3.273M
Minimum
Jun 2019
60.61M
Maximum
Sep 2020
7.578M
Average
2.73M
Median
Mar 2021
Cash from Financing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.026M |
| Palatin Technologies Inc | 4.974M |
| iBio Inc | 4.005M |
| Theriva Biologics Inc | -1.457M |
| Oragenics Inc | -0.1806M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.985M |
| Cash from Investing (Quarterly) | -0.021M |
| Free Cash Flow | -33.08M |
| Free Cash Flow Per Share (Quarterly) | -0.3812 |
| Free Cash Flow to Equity (Quarterly) | -7.173M |
| Free Cash Flow to Firm (Quarterly) | -4.547M |
| Free Cash Flow Yield | -630.1% |